Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

CMS Issues Proposed Coverage Decision for Renal Denervation

Todd Neale

July 11, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Conference News EuroPCR 2025

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Michael O'Riordan

May 21, 2025

News Daily News

Donor Hearts Fare Better With Novel Method After Circulatory Death

Michael O'Riordan

May 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

News Features

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Michael O'Riordan

February 19, 2025

Presentation Controversies and Advances 2025

Cuffless blood pressure devices: Are they ready for prime time?

Presenter: Jennifer L. Cluett

January 30, 2025

News Daily News

CMS Opens Coverage Analysis for Renal Denervation

Todd Neale

January 14, 2025

News Daily News

FDA Issues Draft Guidance for Improving Skin Tone Disparities of Pulse Oximeters

L.A. McKeown

January 08, 2025

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

Advertisement

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

CMS Issues Proposed Coverage Decision for Renal Denervation

June 2025 Dispatch for the CV Team

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI

Donor Hearts Fare Better With Novel Method After Circulatory Death

TCTMD’s Top 10 Most Popular Stories for March 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

TCTMD’s Top 10 Most Popular Stories for February 2025

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Cuffless blood pressure devices: Are they ready for prime time?

CMS Opens Coverage Analysis for Renal Denervation

FDA Issues Draft Guidance for Improving Skin Tone Disparities of Pulse Oximeters

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content